Back
to sessions
Sep 27
Scientific
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, MBA, FASTRO - Henry Ford Hospital/Wayne State University
Credits
| AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
01:30pm - 01:40pm ET
Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis<em></em>
Speaker: Phuoc Tran, MD, PhD - University of Texas MD Anderson Cancer Center, Houston -
01:30pm - 01:40pm ET
Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis<em></em>
Speaker: Phuoc Tran, MD, PhD - University of Texas MD Anderson Cancer Center, Houston -
01:40pm - 01:50pm ET
Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Mark Buyyounouski, MD, MS, FASTRO - Stanford University, Stanford -
01:40pm - 01:50pm ET
Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Mark Buyyounouski, MD, MS, FASTRO - Stanford University, Stanford -
02:00pm - 02:10pm ET
6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy In Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Speaker: Joe Chang, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston -
02:10pm - 02:20pm ET
-
02:20pm - 02:30pm ET